Annual Retained Earnings
-$633.70 M
-$105.32 M-19.93%
December 1, 2024
Summary
- As of March 13, 2025, CCCC annual retained earnings is -$633.70 million, with the most recent change of -$105.32 million (-19.93%) on December 1, 2024.
- During the last 3 years, CCCC annual retained earnings has fallen by -$365.98 million (-136.71%).
- CCCC annual retained earnings is now -659.93% below its all-time high of -$83.39 million, reached on December 31, 2018.
Performance
CCCC Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$633.70 M
-$34.57 M-5.77%
December 31, 2024
Summary
- As of March 13, 2025, CCCC quarterly retained earnings is -$633.70 million, with the most recent change of -$34.57 million (-5.77%) on December 31, 2024.
- Over the past year, CCCC quarterly retained earnings has dropped by -$34.57 million (-5.77%).
- CCCC quarterly retained earnings is now -439.37% below its all-time high of -$117.49 million, reached on December 31, 2019.
Performance
CCCC Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CCCC Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -19.9% | -5.8% |
3 y3 years | -136.7% | -5.8% |
5 y5 years | -439.4% | -5.8% |
CCCC Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -136.7% | at low | -136.7% | at low |
5 y | 5-year | -439.4% | at low | -439.4% | at low |
alltime | all time | -659.9% | at low | -439.4% | at low |
C4 Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | - | -$633.70 M(+5.8%) |
Dec 2024 | -$633.70 M(+19.9%) | - |
Sep 2024 | - | -$599.13 M(+4.3%) |
Jun 2024 | - | -$574.46 M(+3.2%) |
Mar 2024 | - | -$556.74 M(+5.4%) |
Dec 2023 | -$528.38 M(+33.5%) | -$528.38 M(+7.0%) |
Sep 2023 | - | -$493.63 M(+5.8%) |
Jun 2023 | - | -$466.59 M(+8.3%) |
Mar 2023 | - | -$430.67 M(+8.8%) |
Dec 2022 | -$395.89 M | -$395.89 M(+10.4%) |
Sep 2022 | - | -$358.70 M(+9.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | -$326.75 M(+9.2%) |
Mar 2022 | - | -$299.33 M(+11.8%) |
Dec 2021 | -$267.71 M(+45.6%) | -$267.71 M(+6.2%) |
Sep 2021 | - | -$252.06 M(+10.9%) |
Jun 2021 | - | -$227.37 M(+11.0%) |
Mar 2021 | - | -$204.79 M(+11.4%) |
Dec 2020 | -$183.82 M(+56.5%) | -$183.82 M(+13.5%) |
Sep 2020 | - | -$162.03 M(+15.6%) |
Jun 2020 | - | -$140.19 M(+19.3%) |
Dec 2019 | -$117.49 M(+40.9%) | -$117.49 M |
Dec 2018 | -$83.39 M | - |
FAQ
- What is C4 Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for C4 Therapeutics?
- What is C4 Therapeutics annual retained earnings year-on-year change?
- What is C4 Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for C4 Therapeutics?
- What is C4 Therapeutics quarterly retained earnings year-on-year change?
What is C4 Therapeutics annual retained earnings?
The current annual retained earnings of CCCC is -$633.70 M
What is the all time high annual retained earnings for C4 Therapeutics?
C4 Therapeutics all-time high annual retained earnings is -$83.39 M
What is C4 Therapeutics annual retained earnings year-on-year change?
Over the past year, CCCC annual retained earnings has changed by -$105.32 M (-19.93%)
What is C4 Therapeutics quarterly retained earnings?
The current quarterly retained earnings of CCCC is -$633.70 M
What is the all time high quarterly retained earnings for C4 Therapeutics?
C4 Therapeutics all-time high quarterly retained earnings is -$117.49 M
What is C4 Therapeutics quarterly retained earnings year-on-year change?
Over the past year, CCCC quarterly retained earnings has changed by -$34.57 M (-5.77%)